Drugmakers plan to raise US prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as President Trump pressures ...

That fourth drug is Pomalyst, a treatment from Bristol Myers Squibb for multiple myeloma. That’s a relatively uncommon cancer ...

The Inflation Reduction Act introduced Medicare drug price negotiations to reduce treatment costs, enhance access, and potentially reshape prescribing patterns in oncology and hematology. The ...

Opportunities in the ER+/HER2- breast cancer market include the growth of novel CDK4/6 inhibitors and next-generation SERDs, offering advanced treatment options. Strong R&D from players like ...